Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 9-6400 Millcreek Drive MISSISSAUGA ON L5N 3E7 |
Tel: | N/A |
Website: | https://www.neupath.com |
IR: | See website |
Key People | ||
Joseph Walewicz Chief Executive Officer, Director | Jeff Zygouras Chief Financial Officer |
Business Overview |
NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses. |
Financial Overview |
For the fiscal year ended 31 December 2023, NeuPath Health Inc revenues increased 6% to C$66.1M. Net loss decreased 97% to C$107K. Revenues reflect Clinic revenue segment increase of 4% to C$61M, Non-clinic revenue segment increase of 29% to C$5.1M. Lower net loss reflects General and administrative expenses - decrease of 68% to C$2.4M (expense), Impairment decrease from C$1.9M (expense) to C$0K. |
Employees: | 156 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $18.21M as of Dec 31, 2023 |
Annual revenue (TTM): | $66.10M as of Dec 31, 2023 |
EBITDA (TTM): | $3.05M as of Dec 31, 2023 |
Net annual income (TTM): | -$0.11M as of Dec 31, 2023 |
Free cash flow (TTM): | $2.68M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $8.94M as of Dec 31, 2023 |
Shares outstanding: | 56,293,000 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |